Document Details
Form
Filing Date
Dec 3, 2019
Document Date
Dec 2, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.
Filer
Hirmand Mohammad
Turning Point Therapeutics is now a
Bristol Myers Squibb company
Select OK for information about Turning Point Therapeutics.
Select BMS to learn more about Bristol Myers Squibb